DGK ζ is key for actin cytoskeleton remodelling at the B cell immune synapse

by Centro Nacional de Biotecnología (CNB)

DGK (diacylglycerol kinases) are proteins known for their role as negative regulators of the immune response of B and T lymphocytes. For this reason, they are under study as therapeutic targets for th...

Read more

Discovered a small protein that synchronizes the circadian clocks in shoots and roots

by CRAG

The CSIC researcher Paloma Mas leads a study published in Nature Plants demonstrating that the clock protein ELF4 moves in synch with temperature to coordinate rhythms in shoots and roots.

Read more

DRUG TARGETS: The heat shock protein 90 inhibitor ganetespib failed to improve outcomes when added to chemotherapy in advance NSCLC (phase III GALAXY-2 trial). Samples were obtained for biomarker studies; results not yet reported

by OncoDNA

Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non–Small-Cell Lung Cancer (GALAXY-2)

Read more

Experts in G protein-coupled receptors meet at the UB to discuss new pharmacological perspectives

by Hospital Universitari de Bellvitge

Within the framework of the X Esteve Foundation Discussion Group, on February 13th and 14th the tenth meeting of the working group on new advances in the field of G-protein coupled receptors (GPCR) wa...

Read more

Identifican el mecanismo que desencadena un tipo raro de distrofia muscular

by Universitat Autònoma de Barcelona (UAB)

A study led by the IBB-UAB has identified the molecular mechanism through which a protein, when carrying genetic mutations associated with a rare disease known as limb-girdle muscular dystrophy, type ...

Read more

New aspects of Globular Glial Tauopathy could help in the design of more effective drugs against this dementia

by Hospital Universitari de Bellvitge

Tau is not the only protein implicated in protein inclusion formation responsible for this neurodegenerative disease.

Read more

Researchers at IRB Barcelona study how altered protein degradation contributes to the development of tumours

by IRB Barcelona - Instituto de Investigación Biomédica

Published in the journal Nature Cancer, the study analyses how genetic alterations in tumour cells prevent the correct degradation of the proteins involved in tumour development and growth, thereby le...

Read more

Researchers describe a key protein for Epstein-Barr virus infection, which causes mononucleosis and cancer

by IRB Barcelona - Instituto de Investigación Biomédica

Two studies by IRB Barcelona and IBMB-CSIC published in Nature Communications reveal the portal structure of the Epstein-Barr virus and bacteriophage T7. No treatment is currently available for the...

Read more

OncoDNA, a pioneering study demonstrates an impact of molecular profiling on the evolution of cancer

by OncoDNA

OncoDNA, a company which specialises in precision medicine for the treatment and diagnosis of cancer, has participated in a pioneering study on the usefulness and impact of molecular profiling in canc...

Read more

IrsiCaixa develops antibodies that block one of the internalization pathways of the Ebola virus into human cells

by IrsiCaixa

The study demonstrates that the receptor Siglec-1 is used by different virus, such as Ebola, Marburg and HIV, to enter the myeloid cells and develops novel antibodies against this protein.

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream